Loading clinical trials...
Loading clinical trials...
The Use of Alpha-linolenic (ALA), Docosahexaenoic (DHA) and Eicosapanthene (EPA) Esters in the Prevention of Cardiovascular Diseases in Adults.
Conditions
Interventions
Fatty Acids, Unsaturated
Diagnostic Tests
Locations
3
Poland
Department of Family Medicine at Wroclaw Medical University
Wroclaw, Dolny Slask, Poland
Model Practice of a Family Doctor Maria Bujnowska-Fedak
Wroclaw, Dolny Slask, Poland
TIGmed Private Medical Practice
Wroclaw, Dolny Slask, Poland
Start Date
December 9, 2020
Primary Completion Date
December 31, 2021
Completion Date
June 30, 2022
Last Updated
February 8, 2021
NCT06916455
NCT06736925
NCT06665464
NCT03155659
NCT05529576
NCT02592109
Lead Sponsor
Wroclaw Medical University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions